Showing results (1-10 of 240) with videos related to
Sort By:
Pageof 24
Advances in Internal Medicine|January 15, 2000
Prothrombotic effects of angiotensinN J Brown, D E VaughanTrends in Cardiovascular Medicine|January 15, 2011
The Renin-Angiotensin and fibrinolytic systems co-conspirators in the pathogenesis of ischemic cardiovascular diseaseN J Brown, D E VaughanHypertension (Dallas, Tex. : 1979)|August 24, 1999
Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humansN J Brown, M Agirbasli, D E VaughanThrombosis and Haemostasis|March 1, 1997
Selective stimulation of tissue-type plasminogen activator (t-PA) in vivo by infusion of bradykininN J Brown, J H Nadeau, D E VaughanHypertension (Dallas, Tex. : 1979)|June 18, 1999
Bradykinin stimulates tissue plasminogen activator release in human vasculatureN J Brown, J V Gainer, C M Stein, et al.Circulation|August 23, 2000
Angiotensin-converting enzyme insertion/deletion polymorphism modulates the human in vivo metabolism of bradykininL J Murphey, J V Gainer, D E Vaughan, et al.Circulation|November 1, 2000
Bradykinin stimulates tissue plasminogen activator release from human forearm vasculature through B(2) receptor-dependent, NO synthase-independent, and cyclooxygenase-independent pathwayN J Brown, J V Gainer, L J Murphey, et al.Clinical Genetics|July 19, 2002
A comparison of combinatorial partitioning and linear regression for the detection of epistatic effects of the ACE I/D and PAI-1 4G/5G polymorphisms on plasma PAI-1 levelsJ H Moore, J M Lamb, N J Brown, et al.Hypertension (Dallas, Tex. : 1979)|April 17, 2001
Angiotensin-(1-7) does not affect vasodilator or TPA responses to bradykinin in human forearmT Wilsdorf, J V Gainer, L J Murphey, et al.Pageof 24